New protein 'could help scientists understand prostate cancer'

30 May 2012

Researchers based in the UK are confident that a newly-discovered protein could allow for more enhanced prostate cancer treatments to be established.

Scientists at the University of Liverpool have been successful in finding two versions of the PKCZ protein, one of which is deemed 'normal' in appearance and an alternative which is only made in prostate cancer cells.

On top of this discovery, the researchers also pinpointed that this new protein is created using the PRKCZ gene – a sequence which has the potential to influence the behaviour of the life-threatening disease.

Study author Chris Foster, a professor at the University of Liverpool, pointed out: "We now need to discover what role this protein is playing in prostate cancer. If it encourages aggressiveness in the disease then we may be able to develop new drugs that reduce its effects."

People worried about prostate cancer should watch out for common symptoms including the constant need to rush to the toilet to pass urine, pain or difficulty when passing urine or the discovery of blood in the urine or semen.

Posted by Jeanette Royston


Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.
 

Find a treatment, test or scan available at:

or

Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.

or

Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...

Categories

Cancer

© Spire Healthcare Group plc (2016)